The pharmaceutical industry, intellectual property rights and access to medicines in Pakistan

Babar, Zaheer-Ud-Din, Jamshed, Shazia Qasim, Malik, Muhammad Ashar, Löfgren, Hans and Gilani, Anwarul-Hassan 2013, The pharmaceutical industry, intellectual property rights and access to medicines in Pakistan, in The new political economy of pharmaceuticals : production, innovation and TRIPS in the global south, Palgrave Macmillan, London, England, pp.167-184.

Attached Files
Name Description MIMEType Size Downloads

Title The pharmaceutical industry, intellectual property rights and access to medicines in Pakistan
Author(s) Babar, Zaheer-Ud-Din
Jamshed, Shazia Qasim
Malik, Muhammad Ashar
Löfgren, Hans
Gilani, Anwarul-Hassan
Title of book The new political economy of pharmaceuticals : production, innovation and TRIPS in the global south
Editor(s) Löfgren, Hans
Williams, Owain David
Publication date 2013
Series International political economy series
Chapter number 9
Total chapters 13
Start page 167
End page 184
Total pages 18
Publisher Palgrave Macmillan
Place of Publication London, England
Summary The pharmaceutical industry in Pakistan is worth around US$ l.18 billion, with annual growth in 2010 approaching 10 per cent (Khan, 2012). There are more than 650 registered companies, including 31 multinationals, which in 2006 had a market share in value terms of 53.3 per cent, with national firms controlling the remaining 46.7 per cent (IMS Health, 2007). In 2007 medicines worth about US$100 million were exported. Medicines are a vital component of healthcare, and Pakistan spends around three-quarters of its healthcare budget on medicines (WHO, 2004). This chapter provides an overview, from a public health perspective, of the national pharmaceutical market and the development of drug policies and regulation. Pakistan adopted a Trade Related Aspects of Intellectual Property Rights (TRIPS) compliant patent regime in 2000, and the intersection between patents and public health is a central policy challenge. This chapter highlights key issues related to intellectual property, Free Trade Agreements (FTAs), and production and access to medicines.
ISBN 9780230284630
Language eng
Field of Research 160508 Health Policy
160699 Political Science not elsewhere classified
180115 Intellectual Property Law
Socio Economic Objective 860899 Human Pharmaceutical Products not elsewhere classified
HERDC Research category B1 Book chapter
ERA Research output type B Book chapter
HERDC collection year 2013
Persistent URL http://hdl.handle.net/10536/DRO/DU:30056181

Document type: Book Chapter
Collection: School of Humanities and Social Sciences
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Access Statistics: 59 Abstract Views, 5 File Downloads  -  Detailed Statistics
Created: Wed, 25 Sep 2013, 10:48:12 EST by Leanne Swaneveld

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.